149 related articles for article (PubMed ID: 27341781)
1. (-)-Epicatechin derivate from Orostachys japonicus as potential inhibitor of the human butyrylcholinesterase.
Kim JH; Lee SH; Lee HW; Sun YN; Jang WH; Yang SY; Jang HD; Kim YH
Int J Biol Macromol; 2016 Oct; 91():1033-9. PubMed ID: 27341781
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory activity of (-)-epicatechin-3,5-O-digallate on α-glucosidase and in silico analysis.
Kim JH; Kim HY; Yang SY; Kim JB; Jin CH; Kim YH
Int J Biol Macromol; 2018 Feb; 107(Pt A):1162-1167. PubMed ID: 28958819
[TBL] [Abstract][Full Text] [Related]
3. A new epicatechin gallate and calpain inhibitory activity from Orostachys japonicus.
Kim HJ; Lee JY; Kim SM; Park DA; Jin C; Hong SP; Lee YS
Fitoterapia; 2009 Jan; 80(1):73-6. PubMed ID: 18977282
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
[TBL] [Abstract][Full Text] [Related]
5. 2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure-activity relationship (SAR) studies.
Mohamed T; Rao PPN
Eur J Med Chem; 2017 Jan; 126():823-843. PubMed ID: 27951490
[TBL] [Abstract][Full Text] [Related]
6. Mannich-Benzimidazole Derivatives as Antioxidant and Anticholinesterase Inhibitors: Synthesis, Biological Evaluations, and Molecular Docking Study.
Alpan AS; Sarıkaya G; Çoban G; Parlar S; Armagan G; Alptüzün V
Arch Pharm (Weinheim); 2017 Jul; 350(7):. PubMed ID: 28379621
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors.
Liu HR; Liu XJ; Fan HQ; Tang JJ; Gao XH; Liu WK
Bioorg Med Chem; 2014 Nov; 22(21):6124-33. PubMed ID: 25260958
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of berberine-thiophenyl hybrids as multi-functional agents: Inhibition of acetylcholinesterase, butyrylcholinesterase, and Aβ aggregation and antioxidant activity.
Su T; Xie S; Wei H; Yan J; Huang L; Li X
Bioorg Med Chem; 2013 Sep; 21(18):5830-40. PubMed ID: 23932451
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
[TBL] [Abstract][Full Text] [Related]
12. Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
Kurt BZ; Gazioglu I; Basile L; Sonmez F; Ginex T; Kucukislamoglu M; Guccione S
Eur J Med Chem; 2015 Sep; 102():80-92. PubMed ID: 26244990
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors.
Xing W; Fu Y; Shi Z; Lu D; Zhang H; Hu Y
Eur J Med Chem; 2013 May; 63():95-103. PubMed ID: 23466605
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
Manral A; Saini V; Meena P; Tiwari M
Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
Huang L; Luo Z; He F; Lu J; Li X
Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
[TBL] [Abstract][Full Text] [Related]
16. Discovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines.
Lodarski K; Jończyk J; Guzior N; Bajda M; Gładysz J; Walczyk J; Jeleń M; Morak-Młodawska B; Pluta K; Malawska B
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):98-106. PubMed ID: 24666296
[TBL] [Abstract][Full Text] [Related]
17. The insight of in vitro and in silico studies on cholinesterase inhibitors from the roots of Cimicifuga dahurica (Turcz.) Maxim.
Kim JH; Thao NP; Han YK; Lee YS; Luyen BTT; Oanh HV; Kim YH; Yang SY
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1174-1180. PubMed ID: 30286669
[TBL] [Abstract][Full Text] [Related]
18. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.
Altıntop MD; Gurkan-Alp AS; Ozkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2013 Aug; 346(8):571-6. PubMed ID: 23881696
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
